Cargando…
Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma
Mantle cell lymphoma (MCL) is a relatively rare subtype of non-Hodgkin’s lymphoma. To identify molecular biomarkers in MCL, we performed immunohistochemistry tissue arrays using biopsies from 64 MCL patients diagnosed in West China Hospital from 2012 to 2016. TP53 mutation status in those patients w...
Autores principales: | Jing, Caixia, Zheng, Yuhuan, Feng, Yu, Cao, Xia, Xu, Caigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185106/ https://www.ncbi.nlm.nih.gov/pubmed/34099776 http://dx.doi.org/10.1038/s41598-021-91433-7 |
Ejemplares similares
-
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study
por: Nordström, Lena, et al.
Publicado: (2014) -
SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma
por: Narurkar, Roshni, et al.
Publicado: (2016) -
Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: A meta-analysis
por: Lee, Woojoo, et al.
Publicado: (2019) -
The expression and clinical significance of programmed cell death receptor 1 and its ligand in tumor tissues of patients with extranodal nasal NK/T cell lymphoma
por: Feng, Yu, et al.
Publicado: (2022) -
Highly sensitive and specific in situ hybridization assay for quantification of SOX11 mRNA in mantle cell lymphoma reveals association of TP53 mutations with negative and low SOX11 expression
por: Federmann, Birgit, et al.
Publicado: (2020)